HI
TXG icon

Harbour Investments’s 10x Genomics TXG Stock Holding History

Harbour Investments’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.84K Buy
322
+95
+42% +$1.9K ﹤0.01% 3451
2025
Q4 		$3.7K Hold
227
– – ﹤0.01% 3128
2025
Q3 		$2.65K Hold
227
– – ﹤0.01% 3198
2025
Q2 		$2.63K Hold
227
– – ﹤0.01% 3059
2025
Q1 		$1.98K Buy
227
+38
+20% +$479 ﹤0.01% 3086
2024
Q4 		$2.71K Buy
189
+120
+174% +$1.89K ﹤0.01% 2929
2024
Q3 		$1.56K Buy
69
+44
+176% +$910 ﹤0.01% 2991
2024
Q2 		$486 Hold
25
– – ﹤0.01% 3089
2024
Q1 		$938 Hold
25
– – ﹤0.01% 2935
2023
Q4 		$1.4K Hold
25
– – ﹤0.01% 2760
2023
Q3 		$1.03K Sell
25
-90
-78% -$4.68K ﹤0.01% 2694
2023
Q2 		$6.42K Hold
115
– – ﹤0.01% 2200
2023
Q1 		$6.42K Buy
115
+90
+360% +$4.2K ﹤0.01% 2195
2022
Q4 		$911 Sell
25
-2
-7% -$65 ﹤0.01% 2703
2022
Q3 		$1K Hold
27
– – ﹤0.01% 2665
2022
Q2 		$1K Buy
+27
New +$1.4K ﹤0.01% 2665
2021
Q4 		$4K Sell
27
-8
-23% -$1.23K ﹤0.01% 2267
2021
Q3 		$5K Buy
35
+4
+13% +$687 ﹤0.01% 3025
2021
Q2 		$6K Buy
31
+5
+19% +$905 ﹤0.01% 2995
2021
Q1 		$5K Buy
+26
New +$4.49K ﹤0.01% 2939

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harbour Investments's TXG Position: Q1 2026 in Review

Harbour Investments increased its 10x Genomics (TXG) stake by 42% in Q1 2026, buying an estimated $1.9K and bringing the position to 322 shares worth $6.84K. The position accounts for ﹤0.01% of the portfolio, ranked #3451.

Harbour Investments first reported a position in TXG in Q1 2021 and has held it in 20 quarters since. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Harbour Investments held 322 shares of 10x Genomics worth $6.84K as of Q1 2026.
  • Harbour Investments bought 95 10x Genomics shares in Q1 2026, an estimated $1.9K.
  • 10x Genomics made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #3451 holding.
  • Harbour Investments first reported a position in 10x Genomics in Q1 2021 and has held it in 20 quarters since.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.